Skip to content

Cross-Cultural Adaptation, Validity and Reliability Test of the Arabic Version of the Maine-Seattle Back Questionnaire

Translation, Cross-Cultural Adaptation, Validity, and Reliability of the Arabic Version of the Maine-Seattle Back Questionnaire

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07811414
Enrollment
120
Registered
2026-09-10
Start date
2026-09-01
Completion date
2026-12-30
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cross-cultural Adaptation, Reliability, Validity

Keywords

Translation, cross-cultural adaptation, validity, reliability, Maine-Seattle Back Questionnaire

Brief summary

The purpose of this study is to translate and test face validity, content validity, construct validity, internal consistency reliability, and test-retest reliability of adapted Arabic-language version of MSBQ in patients with low back pain and sciatica.

Detailed description

The Maine-Seattle Back Questionnaire (MSBQ) is a condition-specific instrument developed to assess functional disability in patients with low back pain (LBP) and sciatica. It was derived from a modified version of the Roland-Morris Disability Questionnaire (RMDQ) and has demonstrated good reliability, validity, and responsiveness in its original development study .The MSBQ is concise and easy to administer, making it suitable for both clinical and research settings. Despite the high prevalence of low back pain in Arabic-speaking populations, validated Arabic versions of some LBP-specific questionnaires, including the MSBQ, remain limited. Cultural, linguistic, and contextual factors may influence patient responses, highlighting the need for culturally adapted and psychometrically sound instruments. Developing an Arabic version of the MSBQ would facilitate accurate assessment of disability and enable meaningful comparisons in clinical practice and research. The MSBQ was developed as a 12-item shortened version of the modified RMDQ to reduce respondent burden. It was constructed using qualitative methods and cluster analysis techniques to identify representative and non-redundant items. Its brevity enhances feasibility for self-administration in both home and clinical environments, making it particularly suitable for prospective outcome assessment in routine healthcare settings. The present study is significant as it aims to address this gap through the development and validation of an Arabic version of the MSBQ. Providing a culturally adapted and psychometrically sound instrument will enhance clinical decision-making, standardize outcome measurement, and support patient-centered care among individuals with low back pain and sciatica in Arabic-speaking populations.

Interventions

OTHERNo intervention

No intervention

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 - 45 years representing the target population with sciatica. * Diagnosed with low back or leg pain, with symptoms present for less than 6 months. * Ability to read and write in Arabic - for accurate comprehension and completion of the questionnaire. * Patients will be referred by the physician. * Provide informed consent - indicating willingness to participate in the study voluntarily.

Exclusion criteria

* Prior lumbar spinal surgery. * Presence of serious spinal pathology (fracture, tumor, infection, cauda equina syndrome, inflammatory spinal diseases). * Neurological disorders affecting mobility or cognition. Pregnancy. * Severe cognitive impairment or psychiatric disorders that may interfere with questionnaire completion

Design outcomes

Primary

MeasureTime frameDescription
Content validity7 daysIt is the extent to which questions on the instrument and the scores from these questions represent all possible questions that could be asked about the content or skill. It will be measured by item content validity index and scale content validity indices.
Face validity7 daysThe ability of an instrument to be understandable and relevant for the targeted population. It is the weakest way to establish the validity of the questionnaire. It motivates the respondents to answer more truthfully. It will be assessed by a panel of bilingual experts (clinicians, linguists, and researchers) who will reviewed the translated items for clarity, relevance, and cultural appropriateness.
Construct validity7 daysIt refers to validating your constructs based on their pattern of correlations with other variables assumed to be indicators of or theoretically related to the construct of interest. It will be assessed by factor analysis, convergent and divergent validity.

Secondary

MeasureTime frameDescription
Internal consistency7 daysIt indicates how well the items on a tool fit together conceptually. It will be assessed using Cronbach a and the value will be considered excellent above 0.80.
Test-retest reliability7 daysIt is estimated by administering the same test to the same group of respondents at different times. The correlation between the two scores, and often between individual questions, indicates the stability of the instrument. It will be evaluated by the two way mixed intra class correlation coefficient with 95% confidence intervals, values of equal or more than 0.8 were considered as a high level of correlation.
Feasibility of the Arabic Version of the Maine-Seattle Back Questionnaire (MSBQ)7 daysThe medical committee agreed to judge feasibility using two factors ( time and missing items) regarding translated instruments. It will be evaluated by the assessment of the frequency of missing answers per item and the time needed to fill it out.

Countries

Egypt

Contacts

CONTACTOmar M Elbastawesy, Bachelor
omarmouness@gmail.com01274284008
CONTACTKarima S Mohamed, PHD
Karimasalah33@yahoo.com01140306696
STUDY_CHAIRHaytham M Elhafez

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026